Skip to main content
MBOT logo

MBOT · Microbot Medical Inc. · Fails to Deliver

Track MBOT — free
$0.96 +0.01 (+1.18%)
Market Cap
$63.99M
Shares
67.16M
Volume · Oct 20 563.21K Avg daily vol (3M) 658.58K

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-09-30 16,627 $1.25 $20,784
2026-09-29 11,864 $1.25 $14,830
2026-09-28 13,730 $1.28 $17,574
2026-09-24 230 $1.31 $301
2026-09-23 165 $1.38 $228
2026-09-22 780 $1.35 $1,053
2026-09-21 8,517 $1.36 $11,583
2026-09-18 1,674 $1.42 $2,377
2026-09-17 56 $1.44 $81
2026-09-16 10,325 $1.44 $14,868
2026-09-15 25,347 $1.45 $36,753
2026-09-14 53,204 $1.45 $77,146
2026-09-11 78,840 $1.46 $115,106
2026-09-10 75,081 $1.46 $109,618
2026-09-09 44,733 $1.50 $67,100
2026-09-08 9,612 $1.44 $13,841
2026-09-04 6,537 $1.44 $9,413
2026-09-03 25,546 $1.46 $37,297
2026-09-02 8,743 $1.47 $12,852
2026-09-01 12,549 $1.49 $18,698
2026-08-31 15,023 $1.48 $22,234
2026-08-28 1,622 $1.50 $2,433
2026-08-27 11,934 $1.52 $18,140
2026-08-25 45,783 $1.48 $67,759
2026-08-24 36,191 $1.50 $54,287
2026-08-21 37,182 $1.49 $55,401
2026-08-20 21,085 $1.55 $32,682
2026-08-19 3,074 $1.47 $4,519
2026-08-18 765 $1.51 $1,155
2026-08-14 8,991 $1.68 $15,105
2026-08-13 951 $1.74 $1,655
2026-08-12 17,371 $1.68 $29,183
2026-08-11 17,279 $1.94 $33,521
2026-08-10 28,395 $1.89 $53,667
2026-08-07 34 $1.80 $61
2026-08-06 86,314 $1.85 $159,681
2026-08-05 67,978 $1.82 $123,720
2026-08-04 119,027 $1.77 $210,678
2026-08-03 43,454 $1.72 $74,741
2026-07-31 12,621 $1.74 $21,961
2026-07-29 1,100 $1.68 $1,848
2026-07-28 986 $1.74 $1,716
2026-07-27 1 $1.71 $2
2026-07-24 1 $1.76 $2
2026-07-23 7,174 $1.77 $12,698
2026-07-22 20,668 $1.80 $37,202
2026-07-21 1,247 $1.79 $2,232
2026-07-20 93,345 $1.75 $163,354
Showing 1–48 of 48 settlements
Key facts CIK 883975 CUSIP 59503A204 13F (30d) 5 filings 5 filers Visit website Investor relations